Nov 6 (Reuters) - Neuren Pharmaceuticals :

* ACADIA PHARMACEUTICALS ENTERED INTO AGREEMENT TO SELL RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER FOR US$150M

* ENTITLED TO RECEIVE ONE-THIRD OF NET PROCEEDS FROM DEAL TO SELL RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER

Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))